Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.23245084 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.23245084 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96031476 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.67774563 |
5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.47627568 |
6 | regulation of gamma-delta T cell activation (GO:0046643) | 4.04136201 |
7 | positive thymic T cell selection (GO:0045059) | 3.85868945 |
8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.56056150 |
9 | positive regulation of histone deacetylation (GO:0031065) | 3.46293599 |
10 | detection of bacterium (GO:0016045) | 3.41987317 |
11 | detection of other organism (GO:0098543) | 3.41166410 |
12 | negative regulation of cell killing (GO:0031342) | 3.39314592 |
13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.39314592 |
14 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.36548297 |
15 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.35654735 |
16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33873463 |
17 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.33838658 |
18 | response to peptidoglycan (GO:0032494) | 3.32777540 |
19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.26835141 |
20 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23109933 |
21 | negative T cell selection (GO:0043383) | 3.15263309 |
22 | negative thymic T cell selection (GO:0045060) | 3.09324565 |
23 | natural killer cell differentiation (GO:0001779) | 3.07205318 |
24 | thymic T cell selection (GO:0045061) | 3.06548249 |
25 | leukocyte aggregation (GO:0070486) | 3.04069943 |
26 | germinal center formation (GO:0002467) | 3.00121846 |
27 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.98857827 |
28 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98368313 |
29 | response to laminar fluid shear stress (GO:0034616) | 2.96967448 |
30 | Golgi transport vesicle coating (GO:0048200) | 2.95119997 |
31 | COPI coating of Golgi vesicle (GO:0048205) | 2.95119997 |
32 | regulation of leukocyte degranulation (GO:0043300) | 2.93738783 |
33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.87858688 |
34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.87858688 |
35 | modulation by symbiont of host immune response (GO:0052553) | 2.87858688 |
36 | positive regulation by symbiont of host defense response (GO:0052509) | 2.87858688 |
37 | modulation by symbiont of host defense response (GO:0052031) | 2.87858688 |
38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.87858688 |
39 | negative regulation of myotube differentiation (GO:0010832) | 2.87730218 |
40 | hepatocyte apoptotic process (GO:0097284) | 2.86036997 |
41 | protein localization to endosome (GO:0036010) | 2.84494767 |
42 | embryonic process involved in female pregnancy (GO:0060136) | 2.84461181 |
43 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.82945804 |
44 | neutrophil activation involved in immune response (GO:0002283) | 2.80680589 |
45 | detection of external biotic stimulus (GO:0098581) | 2.80084028 |
46 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.79451348 |
47 | positive T cell selection (GO:0043368) | 2.79203392 |
48 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.78740326 |
49 | regulation of histone H3-K27 methylation (GO:0061085) | 2.76337893 |
50 | positive regulation of B cell differentiation (GO:0045579) | 2.76289799 |
51 | positive regulation of interferon-alpha production (GO:0032727) | 2.74733131 |
52 | positive regulation of lamellipodium assembly (GO:0010592) | 2.74607478 |
53 | apoptotic cell clearance (GO:0043277) | 2.74020031 |
54 | regulation of mast cell degranulation (GO:0043304) | 2.72897311 |
55 | mannose metabolic process (GO:0006013) | 2.70248070 |
56 | positive regulation of protein deacetylation (GO:0090312) | 2.70059338 |
57 | leukocyte cell-cell adhesion (GO:0007159) | 2.69636647 |
58 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.68194411 |
59 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.66194026 |
60 | T cell selection (GO:0045058) | 2.63882881 |
61 | modulation by symbiont of host cellular process (GO:0044068) | 2.63426601 |
62 | response to muramyl dipeptide (GO:0032495) | 2.62984888 |
63 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.62319327 |
64 | regulation of B cell differentiation (GO:0045577) | 2.62157826 |
65 | T cell migration (GO:0072678) | 2.60263297 |
66 | positive regulation of nuclease activity (GO:0032075) | 2.59823733 |
67 | regulation of interferon-alpha production (GO:0032647) | 2.58502431 |
68 | histone H3-K36 demethylation (GO:0070544) | 2.57799488 |
69 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.57429147 |
70 | regulation of T cell tolerance induction (GO:0002664) | 2.56450981 |
71 | activation of Rac GTPase activity (GO:0032863) | 2.55878919 |
72 | growth hormone receptor signaling pathway (GO:0060396) | 2.55668632 |
73 | modulation by virus of host process (GO:0019054) | 2.54907263 |
74 | tolerance induction (GO:0002507) | 2.54897829 |
75 | cortical actin cytoskeleton organization (GO:0030866) | 2.54113747 |
76 | positive regulation of lamellipodium organization (GO:1902745) | 2.53618503 |
77 | negative regulation of bone resorption (GO:0045779) | 2.49634280 |
78 | regulation of cholesterol homeostasis (GO:2000188) | 2.47511151 |
79 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.47279491 |
80 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.47212443 |
81 | NIK/NF-kappaB signaling (GO:0038061) | 2.46743198 |
82 | negative regulation of viral release from host cell (GO:1902187) | 2.46410221 |
83 | pinocytosis (GO:0006907) | 2.45156278 |
84 | response to type I interferon (GO:0034340) | 2.44524988 |
85 | detection of biotic stimulus (GO:0009595) | 2.43271707 |
86 | regulation of ARF GTPase activity (GO:0032312) | 2.42783335 |
87 | response to host (GO:0075136) | 2.42739735 |
88 | response to host defenses (GO:0052200) | 2.42739735 |
89 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.42739735 |
90 | B cell receptor signaling pathway (GO:0050853) | 2.42351745 |
91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.42013796 |
92 | regulation of nuclease activity (GO:0032069) | 2.41928221 |
93 | regulation of early endosome to late endosome transport (GO:2000641) | 2.41664537 |
94 | negative regulation of granulocyte differentiation (GO:0030853) | 2.41246423 |
95 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.41123531 |
96 | negative regulation of stress fiber assembly (GO:0051497) | 2.40958192 |
97 | positive regulation of tolerance induction (GO:0002645) | 2.40421088 |
98 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.38925241 |
99 | low-density lipoprotein particle clearance (GO:0034383) | 2.38628713 |
100 | regulation of cholesterol storage (GO:0010885) | 2.38337826 |
101 | establishment of endothelial barrier (GO:0061028) | 2.38029451 |
102 | negative regulation of interleukin-12 production (GO:0032695) | 2.37999235 |
103 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.36579758 |
104 | regulation of necrotic cell death (GO:0010939) | 2.36448833 |
105 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.36073652 |
106 | cellular extravasation (GO:0045123) | 2.35221244 |
107 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.35082940 |
108 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.35001853 |
109 | endothelial tube morphogenesis (GO:0061154) | 2.33898565 |
110 | morphogenesis of an endothelium (GO:0003159) | 2.33898565 |
111 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.33524583 |
112 | detection of molecule of bacterial origin (GO:0032490) | 2.32649117 |
113 | macrophage activation involved in immune response (GO:0002281) | 2.32646474 |
114 | cellular response to type I interferon (GO:0071357) | 2.32350079 |
115 | type I interferon signaling pathway (GO:0060337) | 2.32350079 |
116 | regulation of regulated secretory pathway (GO:1903305) | 2.32121699 |
117 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.31541635 |
118 | response to host immune response (GO:0052572) | 2.31541635 |
119 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.30330822 |
120 | regulation of defense response to virus by virus (GO:0050690) | 2.29875577 |
121 | positive regulation of Rap GTPase activity (GO:0032854) | 2.29747162 |
122 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.29112878 |
123 | cell-substrate adherens junction assembly (GO:0007045) | 2.29025153 |
124 | focal adhesion assembly (GO:0048041) | 2.29025153 |
125 | regulation of response to interferon-gamma (GO:0060330) | 2.28356000 |
126 | activation of JUN kinase activity (GO:0007257) | 2.28160882 |
127 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.26597021 |
128 | T cell costimulation (GO:0031295) | 2.26342235 |
129 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.24267322 |
130 | response to interleukin-15 (GO:0070672) | 2.24104225 |
131 | cellular response to unfolded protein (GO:0034620) | 2.24054918 |
132 | immunoglobulin mediated immune response (GO:0016064) | 2.21908829 |
133 | regulation of extracellular matrix disassembly (GO:0010715) | 2.21652660 |
134 | regulation of necroptotic process (GO:0060544) | 2.21524354 |
135 | cellular response to growth hormone stimulus (GO:0071378) | 2.21391604 |
136 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.20926263 |
137 | lymphocyte costimulation (GO:0031294) | 2.19133796 |
138 | negative regulation of fatty acid transport (GO:2000192) | 2.18533388 |
139 | positive regulation of p38MAPK cascade (GO:1900745) | 2.18484050 |
140 | regulation of erythrocyte differentiation (GO:0045646) | 2.16159068 |
141 | positive regulation of interferon-beta production (GO:0032728) | 2.15268047 |
142 | barbed-end actin filament capping (GO:0051016) | 2.15221874 |
143 | pentose-phosphate shunt (GO:0006098) | 2.14807863 |
144 | negative regulation of phagocytosis (GO:0050765) | 2.14091081 |
145 | apoptotic process involved in morphogenesis (GO:0060561) | 2.13231186 |
146 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.12443630 |
147 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.12443630 |
148 | T cell apoptotic process (GO:0070231) | 2.12292156 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40040401 |
2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.31950213 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.13235851 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03936494 |
5 | MYC_22102868_ChIP-Seq_BL_Human | 3.01226425 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.69569398 |
7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.67381302 |
8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45946319 |
9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27549354 |
10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.22353253 |
11 | MAF_26560356_Chip-Seq_TH1_Human | 2.20257248 |
12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.19847480 |
13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.19826493 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18076188 |
15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.12820207 |
16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08716880 |
17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.06070773 |
18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01371536 |
19 | * MYB_26560356_Chip-Seq_TH2_Human | 1.97068226 |
20 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96888417 |
21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94984716 |
22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94011321 |
23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.93773585 |
24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.88808168 |
25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88632143 |
26 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.86124051 |
27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.84250878 |
28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.83921688 |
29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82033233 |
30 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.81410519 |
31 | MYB_26560356_Chip-Seq_TH1_Human | 1.80543903 |
32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.80146056 |
33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79691689 |
34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74815644 |
35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74381242 |
36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73656605 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73222311 |
38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71584972 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68777971 |
40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68612555 |
41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63161572 |
42 | KDM2B_26808549_Chip-Seq_K562_Human | 1.61915005 |
43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59422567 |
44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53989239 |
45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.53936696 |
46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52582748 |
47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52450666 |
48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52309786 |
49 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50589474 |
50 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.50077563 |
51 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.49135590 |
52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45277526 |
53 | P68_20966046_ChIP-Seq_HELA_Human | 1.45030053 |
54 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.44024451 |
55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.43405520 |
56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41641764 |
57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.41534524 |
58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38850894 |
59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38500717 |
60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38459214 |
61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36213854 |
62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.35447778 |
63 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.35264993 |
64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34953711 |
65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34953117 |
66 | MAF_26560356_Chip-Seq_TH2_Human | 1.32607298 |
67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32192789 |
68 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30242091 |
69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29787214 |
70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29743272 |
71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29153942 |
72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28571347 |
73 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28531076 |
74 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27683349 |
75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27535522 |
76 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.27489297 |
77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.24866787 |
78 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.23341061 |
79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23198705 |
80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22340550 |
81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21333966 |
82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21240919 |
83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21162613 |
84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.20544447 |
85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.19132095 |
86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18457506 |
87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16639362 |
88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15680972 |
89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15542265 |
90 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.12767229 |
91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12292640 |
92 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.12281445 |
93 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12138137 |
94 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11455264 |
95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11228974 |
96 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.10913320 |
97 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10863052 |
98 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10219014 |
99 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10200675 |
100 | GATA2_19941826_ChIP-Seq_K562_Human | 1.10005811 |
101 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09706566 |
102 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08112035 |
103 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08002945 |
104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07284592 |
105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06651196 |
106 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05692846 |
107 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05680527 |
108 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05020832 |
109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04865619 |
110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04704574 |
111 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03698871 |
112 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03427845 |
113 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03032697 |
114 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00878442 |
115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00560222 |
116 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00378155 |
117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99409559 |
118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98363677 |
119 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98299547 |
120 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97465964 |
121 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.96831516 |
122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96678780 |
123 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96594970 |
124 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95909503 |
125 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95696612 |
126 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95513235 |
127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95389895 |
128 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94505839 |
129 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93497111 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003300_gastrointestinal_ulcer | 3.21643694 |
2 | MP0005451_abnormal_body_composition | 2.94353702 |
3 | MP0003705_abnormal_hypodermis_morpholog | 2.67416778 |
4 | MP0000685_abnormal_immune_system | 2.43402775 |
5 | MP0003303_peritoneal_inflammation | 2.36439042 |
6 | MP0005058_abnormal_lysosome_morphology | 2.17545455 |
7 | MP0010352_gastrointestinal_tract_polyps | 2.12566897 |
8 | MP0001835_abnormal_antigen_presentation | 2.11700644 |
9 | MP0009278_abnormal_bone_marrow | 2.05987474 |
10 | MP0002166_altered_tumor_susceptibility | 2.05282773 |
11 | MP0003436_decreased_susceptibility_to | 2.02892728 |
12 | MP0008260_abnormal_autophagy | 2.01234114 |
13 | MP0003566_abnormal_cell_adhesion | 1.99700733 |
14 | MP0003763_abnormal_thymus_physiology | 1.92965180 |
15 | MP0005387_immune_system_phenotype | 1.91629304 |
16 | MP0001790_abnormal_immune_system | 1.91629304 |
17 | MP0004947_skin_inflammation | 1.89278028 |
18 | MP0001800_abnormal_humoral_immune | 1.87092965 |
19 | MP0002396_abnormal_hematopoietic_system | 1.84598753 |
20 | MP0005464_abnormal_platelet_physiology | 1.84377879 |
21 | MP0009840_abnormal_foam_cell | 1.76681125 |
22 | MP0005671_abnormal_response_to | 1.76008344 |
23 | MP0002452_abnormal_antigen_presenting | 1.72841062 |
24 | MP0005000_abnormal_immune_tolerance | 1.71899934 |
25 | MP0002877_abnormal_melanocyte_morpholog | 1.70925758 |
26 | MP0002420_abnormal_adaptive_immunity | 1.68086045 |
27 | MP0001819_abnormal_immune_cell | 1.67147765 |
28 | MP0005025_abnormal_response_to | 1.66516884 |
29 | MP0002723_abnormal_immune_serum | 1.66120544 |
30 | MP0002419_abnormal_innate_immunity | 1.65974296 |
31 | MP0002398_abnormal_bone_marrow | 1.64361178 |
32 | MP0003183_abnormal_peptide_metabolism | 1.63104900 |
33 | MP0005076_abnormal_cell_differentiation | 1.61284402 |
34 | MP0005409_darkened_coat_color | 1.60463077 |
35 | MP0001873_stomach_inflammation | 1.60266861 |
36 | MP0002405_respiratory_system_inflammati | 1.59467112 |
37 | MP0010155_abnormal_intestine_physiology | 1.58448989 |
38 | MP0004808_abnormal_hematopoietic_stem | 1.56227317 |
39 | MP0005023_abnormal_wound_healing | 1.52660826 |
40 | MP0009785_altered_susceptibility_to | 1.50941222 |
41 | MP0003172_abnormal_lysosome_physiology | 1.50127221 |
42 | MP0006054_spinal_hemorrhage | 1.49766951 |
43 | MP0001545_abnormal_hematopoietic_system | 1.48690183 |
44 | MP0005397_hematopoietic_system_phenotyp | 1.48690183 |
45 | MP0006082_CNS_inflammation | 1.45428081 |
46 | MP0009333_abnormal_splenocyte_physiolog | 1.44538295 |
47 | MP0004185_abnormal_adipocyte_glucose | 1.43734087 |
48 | MP0003191_abnormal_cellular_cholesterol | 1.43701064 |
49 | MP0000716_abnormal_immune_system | 1.43039620 |
50 | MP0002722_abnormal_immune_system | 1.39588418 |
51 | MP0002006_tumorigenesis | 1.38356289 |
52 | MP0000689_abnormal_spleen_morphology | 1.36091057 |
53 | MP0004264_abnormal_extraembryonic_tissu | 1.36071432 |
54 | MP0004858_abnormal_nervous_system | 1.33922663 |
55 | MP0003866_abnormal_defecation | 1.33159304 |
56 | MP0001845_abnormal_inflammatory_respons | 1.32669326 |
57 | MP0000465_gastrointestinal_hemorrhage | 1.32546031 |
58 | MP0002429_abnormal_blood_cell | 1.28146872 |
59 | MP0000678_abnormal_parathyroid_gland | 1.26470905 |
60 | MP0002796_impaired_skin_barrier | 1.25231796 |
61 | MP0001533_abnormal_skeleton_physiology | 1.22785436 |
62 | MP0010307_abnormal_tumor_latency | 1.21625272 |
63 | MP0002148_abnormal_hypersensitivity_rea | 1.20107131 |
64 | MP0000703_abnormal_thymus_morphology | 1.19390797 |
65 | MP0004510_myositis | 1.19165030 |
66 | MP0003045_fibrosis | 1.17912351 |
67 | MP0003724_increased_susceptibility_to | 1.14102683 |
68 | MP0003091_abnormal_cell_migration | 1.14044564 |
69 | MP0000858_altered_metastatic_potential | 1.12995684 |
70 | MP0008438_abnormal_cutaneous_collagen | 1.09886657 |
71 | MP0004381_abnormal_hair_follicle | 1.09423165 |
72 | MP0002933_joint_inflammation | 1.08915977 |
73 | MP0008961_abnormal_basal_metabolism | 1.07598323 |
74 | MP0003453_abnormal_keratinocyte_physiol | 1.06773602 |
75 | MP0003448_altered_tumor_morphology | 1.06558170 |
76 | MP0003279_aneurysm | 1.06454462 |
77 | MP0000490_abnormal_crypts_of | 1.04893201 |
78 | MP0002009_preneoplasia | 1.02517063 |
79 | MP0005310_abnormal_salivary_gland | 1.02463843 |
80 | MP0002132_abnormal_respiratory_system | 1.01968649 |
81 | MP0005666_abnormal_adipose_tissue | 1.00003083 |
82 | MP0001348_abnormal_lacrimal_gland | 0.99589692 |
83 | MP0008469_abnormal_protein_level | 0.99432831 |
84 | MP0000609_abnormal_liver_physiology | 0.96561741 |
85 | MP0000733_abnormal_muscle_development | 0.93126390 |
86 | MP0003329_amyloid_beta_deposits | 0.92450663 |
87 | MP0003656_abnormal_erythrocyte_physiolo | 0.90795898 |
88 | MP0005360_urolithiasis | 0.90247371 |
89 | MP0000343_altered_response_to | 0.89708882 |
90 | MP0002998_abnormal_bone_remodeling | 0.88367343 |
91 | MP0005375_adipose_tissue_phenotype | 0.87665758 |
92 | MP0003828_pulmonary_edema | 0.87585749 |
93 | MP0004130_abnormal_muscle_cell | 0.87276112 |
94 | MP0001849_ear_inflammation | 0.87047246 |
95 | MP0009643_abnormal_urine_homeostasis | 0.86449940 |
96 | MP0002138_abnormal_hepatobiliary_system | 0.86197621 |
97 | MP0009931_abnormal_skin_appearance | 0.85764136 |
98 | MP0001853_heart_inflammation | 0.85723983 |
99 | MP0001663_abnormal_digestive_system | 0.85264407 |
100 | MP0005670_abnormal_white_adipose | 0.84395107 |
101 | MP0001958_emphysema | 0.84048691 |
102 | MP0001851_eye_inflammation | 0.84041651 |
103 | MP0010234_abnormal_vibrissa_follicle | 0.82949765 |
104 | MP0003075_altered_response_to | 0.82749310 |
105 | MP0005501_abnormal_skin_physiology | 0.82214849 |
106 | MP0005166_decreased_susceptibility_to | 0.81440156 |
107 | MP0005083_abnormal_biliary_tract | 0.78721882 |
108 | MP0000604_amyloidosis | 0.78605144 |
109 | MP0002019_abnormal_tumor_incidence | 0.78365913 |
110 | MP0002136_abnormal_kidney_physiology | 0.76570815 |
111 | MP0001216_abnormal_epidermal_layer | 0.76506834 |
112 | MP0000249_abnormal_blood_vessel | 0.76185282 |
113 | MP0000477_abnormal_intestine_morphology | 0.75016284 |
114 | MP0000598_abnormal_liver_morphology | 0.74628784 |
115 | MP0001915_intracranial_hemorrhage | 0.73968513 |
116 | MP0005390_skeleton_phenotype | 0.72902439 |
117 | MP0010630_abnormal_cardiac_muscle | 0.71885182 |
118 | MP0001243_abnormal_dermal_layer | 0.71510395 |
119 | MP0000003_abnormal_adipose_tissue | 0.70852020 |
120 | MP0000767_abnormal_smooth_muscle | 0.70383257 |
121 | MP0000371_diluted_coat_color | 0.69699717 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 3.56117432 |
2 | Abnormality of the nasal mucosa (HP:0000433) | 3.38323453 |
3 | Cerebral aneurysm (HP:0004944) | 3.37408105 |
4 | Nasal polyposis (HP:0100582) | 3.34170620 |
5 | Recurrent abscess formation (HP:0002722) | 3.29171767 |
6 | Pustule (HP:0200039) | 3.20186618 |
7 | Recurrent viral infections (HP:0004429) | 3.08232368 |
8 | Recurrent bacterial skin infections (HP:0005406) | 3.05972904 |
9 | Recurrent fungal infections (HP:0002841) | 3.04071565 |
10 | Polycythemia (HP:0001901) | 2.94733888 |
11 | Colitis (HP:0002583) | 2.89429552 |
12 | Dysostosis multiplex (HP:0000943) | 2.86612827 |
13 | Autoimmune thrombocytopenia (HP:0001973) | 2.83658959 |
14 | Inflammation of the large intestine (HP:0002037) | 2.83408168 |
15 | Spontaneous hematomas (HP:0007420) | 2.80719335 |
16 | Gastrointestinal inflammation (HP:0004386) | 2.80303120 |
17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.78672938 |
18 | Hematochezia (HP:0002573) | 2.74234821 |
19 | Myositis (HP:0100614) | 2.72665556 |
20 | Broad face (HP:0000283) | 2.69966722 |
21 | T lymphocytopenia (HP:0005403) | 2.68835798 |
22 | Chronic otitis media (HP:0000389) | 2.67100997 |
23 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.58670173 |
24 | Mucopolysacchariduria (HP:0008155) | 2.58670173 |
25 | Distal lower limb amyotrophy (HP:0008944) | 2.57850559 |
26 | Aortic aneurysm (HP:0004942) | 2.57844203 |
27 | Recurrent bronchitis (HP:0002837) | 2.54752917 |
28 | Abnormality of the fingertips (HP:0001211) | 2.54619406 |
29 | Abnormality of T cell number (HP:0011839) | 2.54246166 |
30 | Cellulitis (HP:0100658) | 2.53218347 |
31 | Interstitial pulmonary disease (HP:0006530) | 2.47115069 |
32 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44787876 |
33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44787876 |
34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44787876 |
35 | Fatigue (HP:0012378) | 2.44042792 |
36 | Obstructive sleep apnea (HP:0002870) | 2.42945607 |
37 | Flat acetabular roof (HP:0003180) | 2.42791633 |
38 | Increased connective tissue (HP:0009025) | 2.41541916 |
39 | Increased cerebral lipofuscin (HP:0011813) | 2.41102428 |
40 | IgM deficiency (HP:0002850) | 2.39957736 |
41 | Increased IgE level (HP:0003212) | 2.37039687 |
42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.35275259 |
43 | Vacuolated lymphocytes (HP:0001922) | 2.34854943 |
44 | Gastrointestinal infarctions (HP:0005244) | 2.32745871 |
45 | Thrombocytosis (HP:0001894) | 2.31592934 |
46 | Malnutrition (HP:0004395) | 2.31132966 |
47 | Obstructive lung disease (HP:0006536) | 2.30527012 |
48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.30527012 |
49 | Orchitis (HP:0100796) | 2.21549005 |
50 | Recurrent skin infections (HP:0001581) | 2.20863178 |
51 | Abnormality of T cells (HP:0002843) | 2.19703841 |
52 | Aneurysm (HP:0002617) | 2.18293574 |
53 | Arterial thrombosis (HP:0004420) | 2.16420943 |
54 | Meningitis (HP:0001287) | 2.12615478 |
55 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08726286 |
56 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02747668 |
57 | Thin bony cortex (HP:0002753) | 2.00678641 |
58 | Petechiae (HP:0000967) | 2.00603800 |
59 | Systemic lupus erythematosus (HP:0002725) | 2.00051188 |
60 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99564311 |
61 | Chest pain (HP:0100749) | 1.98750309 |
62 | Osteolytic defects of the hand bones (HP:0009699) | 1.98239901 |
63 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98239901 |
64 | Emphysema (HP:0002097) | 1.98217623 |
65 | Distal lower limb muscle weakness (HP:0009053) | 1.97360436 |
66 | Frequent falls (HP:0002359) | 1.94794910 |
67 | Abnormal platelet function (HP:0011869) | 1.94743650 |
68 | Impaired platelet aggregation (HP:0003540) | 1.94743650 |
69 | Esophageal varix (HP:0002040) | 1.94727168 |
70 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94197869 |
71 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94197869 |
72 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94197869 |
73 | Abnormality of macrophages (HP:0004311) | 1.94150147 |
74 | Gingival bleeding (HP:0000225) | 1.93468298 |
75 | Metaphyseal cupping (HP:0003021) | 1.92665466 |
76 | Reticulocytosis (HP:0001923) | 1.92440082 |
77 | Periodontitis (HP:0000704) | 1.92046628 |
78 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91361502 |
79 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91361502 |
80 | Slow saccadic eye movements (HP:0000514) | 1.91108256 |
81 | Epistaxis (HP:0000421) | 1.90959137 |
82 | Aortic dissection (HP:0002647) | 1.90816940 |
83 | Abnormality of T cell physiology (HP:0011840) | 1.90697676 |
84 | Hand muscle atrophy (HP:0009130) | 1.90404948 |
85 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90268060 |
86 | Leukocytosis (HP:0001974) | 1.89529779 |
87 | Gastrointestinal stroma tumor (HP:0100723) | 1.89406505 |
88 | Increased density of long bones (HP:0006392) | 1.88843207 |
89 | Ulnar bowing (HP:0003031) | 1.88528338 |
90 | Eosinophilia (HP:0001880) | 1.88332825 |
91 | Increased serum ferritin (HP:0003281) | 1.87638284 |
92 | Abnormality of the thoracic spine (HP:0100711) | 1.87537713 |
93 | Upper limb amyotrophy (HP:0009129) | 1.87089308 |
94 | Distal upper limb amyotrophy (HP:0007149) | 1.87089308 |
95 | Papilloma (HP:0012740) | 1.86006127 |
96 | Verrucae (HP:0200043) | 1.86006127 |
97 | Dysmetric saccades (HP:0000641) | 1.85460109 |
98 | Myocardial infarction (HP:0001658) | 1.84883881 |
99 | Abnormal platelet volume (HP:0011876) | 1.84637194 |
100 | Panhypogammaglobulinemia (HP:0003139) | 1.84307661 |
101 | Osteomyelitis (HP:0002754) | 1.84049658 |
102 | Polygenic inheritance (HP:0010982) | 1.83003448 |
103 | Hypertriglyceridemia (HP:0002155) | 1.81395940 |
104 | Hypertensive crisis (HP:0100735) | 1.80323840 |
105 | Chronic diarrhea (HP:0002028) | 1.80003287 |
106 | J-shaped sella turcica (HP:0002680) | 1.79157864 |
107 | Spondylolisthesis (HP:0003302) | 1.79044086 |
108 | Peritonitis (HP:0002586) | 1.78927032 |
109 | Protrusio acetabuli (HP:0003179) | 1.77013234 |
110 | Vasculitis (HP:0002633) | 1.76369693 |
111 | Vertebral compression fractures (HP:0002953) | 1.76276106 |
112 | Prolonged bleeding time (HP:0003010) | 1.75877178 |
113 | Urticaria (HP:0001025) | 1.75869312 |
114 | Loss of speech (HP:0002371) | 1.75661960 |
115 | Asymmetric septal hypertrophy (HP:0001670) | 1.75270080 |
116 | Dilatation of the ascending aorta (HP:0005111) | 1.74101507 |
117 | Disproportionate tall stature (HP:0001519) | 1.73803119 |
118 | Gingivitis (HP:0000230) | 1.72358402 |
119 | Ankyloglossia (HP:0010296) | 1.71194738 |
120 | Thoracic kyphosis (HP:0002942) | 1.71013505 |
121 | Mitral valve prolapse (HP:0001634) | 1.70865742 |
122 | Gastrointestinal dysmotility (HP:0002579) | 1.70256594 |
123 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.69728993 |
124 | Hypoglycemic coma (HP:0001325) | 1.69678130 |
125 | Bicuspid aortic valve (HP:0001647) | 1.69358253 |
126 | Nonimmune hydrops fetalis (HP:0001790) | 1.68354220 |
127 | Retrobulbar optic neuritis (HP:0100654) | 1.67895576 |
128 | Optic neuritis (HP:0100653) | 1.67895576 |
129 | Cervical subluxation (HP:0003308) | 1.67638258 |
130 | IgA deficiency (HP:0002720) | 1.67382392 |
131 | Mediastinal lymphadenopathy (HP:0100721) | 1.66475327 |
132 | Increased mean platelet volume (HP:0011877) | 1.65997270 |
133 | Viral hepatitis (HP:0006562) | 1.64738001 |
134 | Cholecystitis (HP:0001082) | 1.63791738 |
135 | Abnormal gallbladder physiology (HP:0012438) | 1.63791738 |
136 | Achilles tendon contracture (HP:0001771) | 1.63488545 |
137 | Hyperacusis (HP:0010780) | 1.62652997 |
138 | Abnormality of oral frenula (HP:0000190) | 1.61586817 |
139 | Bone pain (HP:0002653) | 1.61479892 |
140 | Persistence of primary teeth (HP:0006335) | 1.59439555 |
141 | Seborrheic dermatitis (HP:0001051) | 1.58813253 |
142 | Long palpebral fissure (HP:0000637) | 1.58039684 |
143 | Abdominal distention (HP:0003270) | 1.56556944 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.87336139 |
2 | PRPF4B | 3.42057763 |
3 | MAP4K1 | 3.21125281 |
4 | ERN1 | 3.17951179 |
5 | PKN2 | 2.99581711 |
6 | SMG1 | 2.94138069 |
7 | EEF2K | 2.62472562 |
8 | RIPK4 | 2.61166960 |
9 | STK10 | 2.49062667 |
10 | EPHB1 | 2.44482320 |
11 | MAP3K10 | 2.31759449 |
12 | LRRK2 | 2.14177879 |
13 | TGFBR2 | 1.99344551 |
14 | TYK2 | 1.94057872 |
15 | TBK1 | 1.91610951 |
16 | JAK3 | 1.87592697 |
17 | PTK6 | 1.86295665 |
18 | CDK12 | 1.84909356 |
19 | TTN | 1.81136270 |
20 | ZAP70 | 1.66654977 |
21 | MAP3K13 | 1.65870688 |
22 | FGFR4 | 1.59479078 |
23 | MST1R | 1.49160969 |
24 | RIPK1 | 1.43886798 |
25 | CAMK1D | 1.41120139 |
26 | SIK1 | 1.40406865 |
27 | JAK1 | 1.38188850 |
28 | ITK | 1.37452300 |
29 | CSK | 1.36481867 |
30 | CDC42BPA | 1.32700111 |
31 | EPHA2 | 1.28563761 |
32 | KSR2 | 1.24813323 |
33 | MAP2K3 | 1.24795565 |
34 | GRK6 | 1.24261044 |
35 | BTK | 1.23906622 |
36 | CSF1R | 1.22348782 |
37 | MARK2 | 1.21739728 |
38 | MAP3K1 | 1.19598001 |
39 | TAOK2 | 1.19155000 |
40 | IKBKE | 1.16508582 |
41 | TAOK3 | 1.16150351 |
42 | ICK | 1.15489935 |
43 | KDR | 1.14847019 |
44 | DMPK | 1.10752059 |
45 | TNK2 | 1.08775799 |
46 | FLT3 | 1.07716563 |
47 | PAK4 | 1.06322991 |
48 | TXK | 1.06259110 |
49 | KIT | 1.02273956 |
50 | PDPK1 | 1.01712025 |
51 | CAMK1G | 1.01624821 |
52 | PRKD2 | 0.97023201 |
53 | BLK | 0.97015553 |
54 | TESK1 | 0.96438431 |
55 | FES | 0.95102424 |
56 | MARK3 | 0.94038056 |
57 | HCK | 0.93392518 |
58 | SIK3 | 0.89655178 |
59 | SCYL2 | 0.89418474 |
60 | MAP3K6 | 0.87928438 |
61 | RPS6KA4 | 0.87816737 |
62 | LCK | 0.86855247 |
63 | TAOK1 | 0.85694877 |
64 | MAP3K14 | 0.85627278 |
65 | MAPK11 | 0.85519888 |
66 | FGFR3 | 0.83161857 |
67 | MTOR | 0.82367565 |
68 | IKBKB | 0.81930786 |
69 | NLK | 0.81526479 |
70 | PTK2 | 0.81086403 |
71 | JAK2 | 0.80661766 |
72 | IRAK3 | 0.79158085 |
73 | IRAK4 | 0.78996974 |
74 | RPS6KA2 | 0.78360574 |
75 | TRPM7 | 0.76963532 |
76 | PIM1 | 0.76104116 |
77 | NEK9 | 0.75770238 |
78 | RPS6KL1 | 0.75439364 |
79 | RPS6KC1 | 0.75439364 |
80 | MAP2K2 | 0.75165331 |
81 | PDGFRA | 0.74013743 |
82 | CDK6 | 0.73696253 |
83 | CHUK | 0.73169877 |
84 | NEK2 | 0.72524561 |
85 | BMX | 0.70205717 |
86 | PDGFRB | 0.70158651 |
87 | STK3 | 0.69357551 |
88 | MAP3K8 | 0.69233298 |
89 | MST4 | 0.68613211 |
90 | STK4 | 0.67519183 |
91 | MAPK15 | 0.67104636 |
92 | CDK4 | 0.66978399 |
93 | NME2 | 0.66776829 |
94 | MAPK12 | 0.65909384 |
95 | CLK1 | 0.65123356 |
96 | LMTK2 | 0.64370021 |
97 | EPHA3 | 0.63136868 |
98 | MAP3K2 | 0.62166664 |
99 | SYK | 0.61446623 |
100 | TEC | 0.60164901 |
101 | RPS6KA6 | 0.58461059 |
102 | DYRK1B | 0.57904378 |
103 | MAP3K7 | 0.57844264 |
104 | IRAK2 | 0.57115340 |
105 | HIPK2 | 0.56992169 |
106 | FGR | 0.54776973 |
107 | TESK2 | 0.54498236 |
108 | PASK | 0.53835599 |
109 | MAPKAPK3 | 0.50789105 |
110 | MAP3K3 | 0.50769339 |
111 | RPS6KB2 | 0.50282858 |
112 | ILK | 0.49628620 |
113 | PRKG2 | 0.48180526 |
114 | MET | 0.47615424 |
115 | PRKCH | 0.47352110 |
116 | MAPK7 | 0.46751773 |
117 | RET | 0.46247408 |
118 | SGK3 | 0.45371983 |
119 | IRAK1 | 0.44483232 |
120 | PAK2 | 0.44456237 |
121 | MAP2K6 | 0.44186141 |
122 | MAPKAPK2 | 0.43946351 |
123 | TGFBR1 | 0.43589266 |
124 | CDK9 | 0.43206853 |
125 | MATK | 0.42592521 |
126 | LYN | 0.41426849 |
127 | PDK1 | 0.41111962 |
128 | PRKD1 | 0.40181528 |
129 | EGFR | 0.39481815 |
130 | STK38 | 0.38824486 |
131 | SIK2 | 0.38758615 |
132 | MAP3K11 | 0.38236808 |
133 | PRKCQ | 0.38195666 |
134 | BRD4 | 0.37922316 |
135 | TYRO3 | 0.37831401 |
136 | CAMKK1 | 0.37646633 |
137 | MELK | 0.37524298 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.66388025 |
2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06562599 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05666555 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.04657562 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02107767 |
6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.88940152 |
7 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.73840457 |
8 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.73683901 |
9 | Measles_Homo sapiens_hsa05162 | 1.70126929 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.68072853 |
11 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67017528 |
12 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.66263482 |
13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61466180 |
14 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.55239175 |
15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50550344 |
16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48738909 |
17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46331901 |
18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41257069 |
19 | Lysosome_Homo sapiens_hsa04142 | 1.40859237 |
20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.38820175 |
21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.37801548 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34414917 |
23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32741232 |
24 | Shigellosis_Homo sapiens_hsa05131 | 1.29479213 |
25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29187507 |
26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27641469 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.27469987 |
28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23478118 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.23346316 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23092797 |
31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21820573 |
32 | Apoptosis_Homo sapiens_hsa04210 | 1.21486851 |
33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21304958 |
34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.20950712 |
35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.20473481 |
36 | Insulin resistance_Homo sapiens_hsa04931 | 1.18922315 |
37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16868358 |
38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16747142 |
39 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.15955953 |
40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15624045 |
41 | Platelet activation_Homo sapiens_hsa04611 | 1.13199474 |
42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12067920 |
43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11202627 |
44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10995265 |
45 | Allograft rejection_Homo sapiens_hsa05330 | 1.09279851 |
46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08878131 |
47 | Hepatitis B_Homo sapiens_hsa05161 | 1.08270499 |
48 | Malaria_Homo sapiens_hsa05144 | 1.07467177 |
49 | Tuberculosis_Homo sapiens_hsa05152 | 1.06178304 |
50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05735128 |
51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.03348561 |
52 | Pertussis_Homo sapiens_hsa05133 | 1.03204673 |
53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00625875 |
54 | Adherens junction_Homo sapiens_hsa04520 | 1.00239916 |
55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.99788110 |
56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99264743 |
57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98554657 |
58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98521745 |
59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.97140261 |
60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96091960 |
61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95591479 |
62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95519213 |
63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95125404 |
64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94728483 |
65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93469849 |
66 | Hepatitis C_Homo sapiens_hsa05160 | 0.93368763 |
67 | Focal adhesion_Homo sapiens_hsa04510 | 0.92871173 |
68 | Lysine degradation_Homo sapiens_hsa00310 | 0.91554213 |
69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90970939 |
70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88375255 |
71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.87543555 |
72 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86310582 |
73 | Salmonella infection_Homo sapiens_hsa05132 | 0.85952333 |
74 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84520019 |
75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83471704 |
76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82617441 |
77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81847578 |
78 | Prion diseases_Homo sapiens_hsa05020 | 0.81214671 |
79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80783905 |
80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79934548 |
81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79244043 |
82 | * Endocytosis_Homo sapiens_hsa04144 | 0.78177448 |
83 | Glioma_Homo sapiens_hsa05214 | 0.78155493 |
84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77667700 |
85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77387035 |
86 | ABC transporters_Homo sapiens_hsa02010 | 0.75789921 |
87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74815898 |
88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73914204 |
89 | Amoebiasis_Homo sapiens_hsa05146 | 0.72690669 |
90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72138303 |
91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72055096 |
92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69836939 |
93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66798459 |
94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64931031 |
95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64893643 |
96 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62169117 |
97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61166131 |
98 | Prostate cancer_Homo sapiens_hsa05215 | 0.60768694 |
99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59470146 |
100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59194945 |
101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55791464 |
102 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55730945 |
103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54364898 |
104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54141712 |
105 | Phagosome_Homo sapiens_hsa04145 | 0.53987823 |
106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53980785 |
107 | Bladder cancer_Homo sapiens_hsa05219 | 0.53108771 |
108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52813365 |
109 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51816424 |
110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51247687 |
111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50280309 |
112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49091721 |
113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48935789 |
114 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47135212 |
115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45785124 |
116 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44233664 |
117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.43355584 |
118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43271490 |
119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42817150 |
120 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.42607662 |